At this year's Two Sessions, the issue of population aging was put on the agenda. The government is working to address the challenges posed by rapid aging to the economy and society, and is expected to introduce more measures to improve the well-being of the elderly. This also allows multinational medical companies that are actively developing health industries in China to see huge market potential. Recently, Huzur Devletsah, President and General Manager of Eli Lilly China, called in an exclusive interview that innovative drugs that are used in the early stages of Alzheimer's disease, target the causes, and can significantly slow the progression of the disease should be included in medical insurance as soon as possible to improve accessibility and affordability for patients. Achieving Early Intervention of Alzheimer's Disease Tehran said that Eli Lilly's vision is to ultimately achieve early intervention of Alzheimer's disease in the next 10 years through timely testing, accurate diagnosis and appropriate treatment.